Biocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...

Twisha Sharma dowry death: Twisha Sharma's mysterious death has become a complex case with her mother-in-law, a retired judge, alleging dru...

Amortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...

Eli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...

Weight loss drug risks: The government has warned of strict regulatory action against those found using surrogate advertising to promote GL...

India's drug regulator has issued a stern warning to pharmaceutical companies. Direct or indirect advertising of weight-loss medicines is n...

Lieutenant Governors of five Union territories now hold new powers. They can authorize officers to search any premises and seize records. T...

The Trump administration is intensifying its scrutiny of pharmaceutical advertising, with the FDA set to issue cease-and-desist notices and...

The Kerala High Court has temporarily halted proceedings against Baba Ramdev, Acharya Balakrishna, and Divya Pharmacy related to a misleadi...

Patanjali Ayurved's MD, Acharya Balkrishna, apologised to the Supreme Court for misleading advertisements, ensuring they won't be repeated....

An official release on Tuesday stated that advertisements of Sensodyne products which make the claims 'Recommended by dentists worldwide' a...

The disclosure from ASCI for April comes a day after the government issued a gag order against Baba Ramdev's company Patanjali Ayurved from...

Ministry sets up panel to suggest stronger criminal procedures against violators. At present, penalties for false claims include “imprisonm...

Most doctors depend on advertisements in medical journals or direct marketing by representatives to gather information about new medication...

Cos say the move contradicts government's health policies besides hurting their investments.

The Drug Controller General Of India (DCGI) has issued showcause notices to Piramal Healthcare, Mankind Pharma and Morepen Laboratories for...

It could be curtains down for advertisements of controversial emergency contraceptive pills (ECPs) such as Cipla’s i-pill and Mankind Pharm...